Michael Roost Clausen

17PUBLICATIONS
95CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumoursLiquid biopsiesIndonesian languages
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Aug 05, 2026
First-line treatment with epcoritamab in combination with bendamustine plus rituximab induces sustained remissions beyond 3 years in patients with follicular lymphoma.

|Apr 14, 2026
Diagnosis-to-treatment interval is associated with outcomes in follicular lymphoma treated with immunochemotherapy.

Prokop Vodička, Tarec C El-Galaly, Vit Prochazka

|Mar 11, 2026
A real-world comparison of CD20xCD3 bispecific antibodies versus chemotherapy regimens in 3+ line relapsed/refractory diffuse large B cell lymphoma.

Emil Ramsø Kyvsgaard, Alexander Djupnes Fuglkjær, Ahmed Ludvigsen Al-Mashhadi

|Dec 02, 2025
FLIPI24: A Modern Prognostic Model and Clinical Trial Enrichment Tool for Newly Diagnosed Follicular Lymphoma.

Matthew J Maurer, Vit K Prochazka, Tarec Christoffer El-Galaly

|Jan 28, 2025
Similar Survival Between Non-Western Immigrant Patients and Danish-Born Patients with Lymphoma: A Danish Population-Based Study.

Mikkel Runason Simonsen, Eva Futtrup Maksten, Lasse Hjort Jakobsen

|Jan 09, 2025
Impact of Trial Eligibility Criteria on Outcomes of 1183 Patients With Follicular Lymphoma Treated in the Real-World Setting.

Tine Litske Bennedsen, Mikkel Runason Simonsen, Paw Jensen

Pageof 3

Frequent Collaborators

4 joint publications

Peter de Nully Brown

4 joint publications

Tarec Christoffer El-Galaly

4 joint publications

Henrik Frederiksen

4 joint publications

Marianne Tang Severinsen